Benfotiamine [CAS No: 22457-89-2], also known as S-benzoylthiamine O-monophosphate, is a highly bioavailable lipid-soluble derivative of Vitamin B1 (Thiamine). As an advanced thiamine analogue, Benfotiamine plays an essential role in maintaining healthy nerve cell metabolism and supporting normal cellular energy production. It is widely used to enhance nerve function, cognitive performance, and metabolic balance, particularly in conditions associated with oxidative stress and high blood glucose levels.
Research has shown that Benfotiamine significantly reduces the formation of advanced glycation end products (AGEs) and restores transketolase activity, which protects neurons from glucose-induced cellular damage. This mechanism is crucial in managing neuropathic discomfort, improving nerve conduction, and supporting long-term vascular, brain, and metabolic health. In addition, Benfotiamine has demonstrated benefits in promoting mood stability, mental clarity, and overall neuroprotection.
Chemox Pharma is a leading manufacturer of Benfotiamine and adheres to international regulatory standards including WHO-GMP, FDA, and DCGI. Our technologically advanced production facility and in-house R&D Centre are dedicated to continuous process improvement, quality enhancement, and cost optimization—enabling us to meet the evolving needs of global pharmaceutical and nutraceutical partners with high-purity, consistently reliable material.